Medline Inc. (MDLN)

Medline Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	26,702	25,507	23,231	21,448
Revenue Growth (YoY)	-	9.80%	8.31%	-
Cost of Revenue	-	18,531	17,346	16,231
Gross Profit	7,337	6,976	5,885	5,217
Selling, General & Admin	-	4,108	3,867	3,676
Other Operating Expenses	0	722	768	680
Operating Expenses	-	4,830	4,635	4,356
Operating Income	2,279	2,146	1,250	861
Interest Expense / Income	855	864	976	872
Other Expense / Income	84	36	10	-21
Pretax Income	1,340	1,246	264	10
Income Tax	72	46	30	35
Net Income	1,268	1,200	234	-25
Net Income Growth	-	412.82%	-	-
Free Cash Flow	1,089	1,405	1,400	-67
Gross Margin	27.48%	27.35%	25.33%	24.32%
Operating Margin	8.54%	8.41%	5.38%	4.01%
Profit Margin	4.75%	4.71%	1.01%	-0.12%
Free Cash Flow Margin	4.08%	5.51%	6.03%	-0.31%
Effective Tax Rate	5.37%	3.69%	11.36%	350.00%
EBITDA	3,278	3,169	2,361	1,915
EBITDA Margin	12.28%	12.42%	10.16%	8.93%
Depreciation & Amortization	1,083	1,059	1,121	1,033
EBIT	2,195	2,110	1,240	882
EBIT Margin	8.22%	8.27%	5.34%	4.11%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).